Oral mucosal immunity and HIV/SIV infection

Area of Science:

• Immunology
• Virology
• Oral Biology

Background:

• Genital and rectal mucosa are primary sites of Human Immunodeficiency Virus (HIV) transmission, driving research into mucosal immunity and vaccines.
• HIV transmission via oral mucosa is rare, suggesting distinct protective mechanisms within the oral environment.

Purpose of the Study:

• To explore the immunological elements and unique defense mechanisms of the oral mucosa against HIV/Simian Immunodeficiency Virus (SIV) infection.
• To investigate how oral mucosal immunity changes during early and chronic HIV infection.
• To identify potential targets for novel mucosal vaccine strategies against HIV and other oral diseases.

Main Methods:

• Review of existing literature on oral mucosal immunity and HIV/SIV infection.
• Analysis of the roles of salivary glands, oral mucosa cellular structure, blood flow, and innate salivary factors.
• Examination of humoral, cellular, and innate immune responses in the oral mucosa during different stages of HIV infection.

Main Results:

• The oral mucosa possesses a multi-faceted defense system, including secretory immunity, unique cellular structures, high blood flow, and innate salivary factors, contributing to resistance against oral HIV/SIV infection.
• Early HIV infection maintains oral mucosal immune functions, but these responses can be impaired in chronic infection.
• Differences in immune defense exist across oral micro-compartments like salivary glands, oral mucosa, and palatine tonsils.

Conclusions:

• Understanding oral mucosal immune mechanisms is crucial for preventing viral and bacterial infections, especially in immunocompromised individuals.
• This knowledge can inform the development of effective mucosal vaccines for HIV/AIDS and other oral conditions like dental caries and periodontal disease.